Hacker News
- US Population Impact of Semaglutide on Obesity and Cardiovascular Disease https://link.springer.com/article/10.1007/s10557-023-07488-3 2 comments
- A projected 93 million US adults who are overweight and obese may be suitable for 2.4 mg dose of semaglutide, a weight loss medication. Its use could result in 43m fewer people with obesity, and prevent up to 1.5m heart attacks, strokes and other adverse cardiovascular events over 10 years. https://link.springer.com/article/10.1007/s10557-023-07488-3 2699 comments science